Filter by: patients
What is Venlafaxine?

Venlafaxine is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). It affects chemicals in the brain that may become unbalanced and cause depression. It is used to treat major depressive disorder, anxiety, and panic disorder.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Depressed mood 789 256 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Major Depressive Disorder 598 145 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Generalized Anxiety Disorder 298 53 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Treat my mood condition(s) 232 83 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Anxious mood 193 79 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Fibromyalgia 140 49 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell

See all 1725 patients currently taking Venlafaxine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
126
Moderate
166
Mild
175
None
180

Commonly reported side effects, conditions, and hospitalizations associated with Venlafaxine

Weight gain 75
Brain zaps 48
Agitation with restlessness 35
Drowsiness 35
Nausea 31
Jittery feeling 29
See all 276 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Venlafaxine. See all 58 dosages

  37.5 mg daily 50 mg daily 75 mg daily 100 mg daily 112.5 mg daily 150 mg daily 225 mg daily 300 mg daily 375 mg daily 450 mg daily
  154 Number of Patients: 154 19 Number of Patients: 19 419 Number of Patients: 419 29 Number of Patients: 29 24 Number of Patients: 24 584 Number of Patients: 584 225 Number of Patients: 225 258 Number of Patients: 258 20 Number of Patients: 20 22 Number of Patients: 22  

Reported Stop Reasons

Why Patients Stopped Taking Venlafaxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 256   Side effects too severe: 37%
Did not seem to work 247   Did not seem to work: 36%
Doctor's advice 180   Doctor's advice: 26%
Other 127   Other: 18%
Expense 65   Expense: 9%
Personal research 39   Personal research: 6%
Course of treatment ended 33   Course of treatment ended: 5%
Change in health plan coverage 18   Change in health plan coverage: 3%
Not indicated 9   Not indicated: 1%

See all 664 patients who’ve stopped taking Venlafaxine

Currently Taking Venlafaxine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Venlafaxine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Venlafaxine

Always
523 81%
Usually
98 15%
Sometimes
14 2%
Never
12 2%

Burden

Difficulty being on treatment

Burden of Venlafaxine

Very
43 7%
Somewhat
71 11%
A little
112 17%
Not at all
421 65%

Cost

Paid out of pocket

Cost of Venlafaxine

$200+
4 1%
$100-199
25 6%
$50-99
34 8%
$25-49
116 27%
< $25
241 57%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 22, 2012.